These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6538287)

  • 1. Renal function and therapeutic concentrations of phenytoin.
    Liponi DF; Winter ME; Tozer TN
    Neurology; 1984 Mar; 34(3):395-7. PubMed ID: 6538287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin binding to partially purified albumin in renal disease.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Feb; 29(2):203-10. PubMed ID: 7460484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
    Tiula E; Tallgren LG; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin binding to human albumin.
    Lecomte M; Zini R; d'Athis P; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):23-8. PubMed ID: 467465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
    Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
    Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
    Reynolds F; Ziroyanis PN; Jones NF; Smith SE
    Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation.
    Monaghan MS; Marx MA; Olsen KM; Turner PD; Bergman KL
    Ther Drug Monit; 2001 Jun; 23(3):263-7. PubMed ID: 11360036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation.
    Soriano VV; Tesoro EP; Kane SP
    Ann Pharmacother; 2017 Aug; 51(8):669-674. PubMed ID: 28470115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of phenytoin protein binding with in vivo haemodialysis in dialysis encephalopathy.
    Steele WH; Lawrence JR; Elliott HL; Whiting B
    Eur J Clin Pharmacol; 1979 Feb; 15(1):69-71. PubMed ID: 421730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure.
    Borgå O; Hoppel C; Odar-Cederlöf I; Garle M
    Clin Pharmacol Ther; 1979 Sep; 26(3):306-14. PubMed ID: 466924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding of digitoxin, valproate and phenytoin in sera from diabetics.
    Doucet J; Fresel J; Hue G; Moore N
    Eur J Clin Pharmacol; 1993; 45(6):577-9. PubMed ID: 8157046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
    Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
    Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of two equations in determining normalized phenytoin concentrations.
    Mauro LS; Mauro VF; Bachmann KA; Higgins JT
    DICP; 1989 Jan; 23(1):64-8. PubMed ID: 2718487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of free phenytoin to serum albumin in cancer patients.
    Umstead GS; Neumann KH
    DICP; 1990 Oct; 24(10):923-6. PubMed ID: 2244404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of phenytoin binding by glycosylation of albumin in IDDM.
    Kemp SF; Kearns GL; Turley CP
    Diabetes; 1987 Apr; 36(4):505-9. PubMed ID: 3817304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
    Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
    Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.